Patients fulfilling | ||||
---|---|---|---|---|
Both sets | ACR set only | AECG set only | Neither set | |
(n = 27) | (n = 8) | (n = 15) | (n = 55) | |
Age (years) | 60.7 ± 11.7 | 46.6 ± 15.8 | 59.3 ± 11.1 | 56.4 ± 14.5 |
Symptom duration (years) | 9.5 ± 7.4 | 2.9 ± 2.4 | 4.7 ± 4.3 | 6.4 ± 5.7 |
Female | 25 (92.6) | 8 (100) | 14 (93.3) | 52 (94.5) |
Xerophthalmia | 26 (96.3) | 6 (75.0) | 14 (93.3) | 50 (90.9) |
Xerostomia | 27 (100) | 6 (75.0) | 15 (100) | 51 (92.7) |
Salivary flow ≤0.1 ml/minute | 18 (66.7) | 0 (0) | 10 (66.7) | 16 (29.1) |
Schirmer’s test ≤5 mm/5 minutes | 22 (81.5) | 1 (12.5) | 12 (80.0) | 13 (23.6) |
OSS ≥3 | 24 (88.9) | 6 (75.0) | 0 (0) | 19 (34.5) |
Anti-SSA or anti-SSB positivity | 18 (66.7) | 4 (50.0) | 4 (26.7) | 1 (1.8) |
ANA ≥1:320 | 25 (92.6) | 5 (62.5) | 8 (53.3) | 18 (32.7) |
RF positivity | 14 (51.9) | 4 (50.0) | 1 (6.7) | 6 (10.9) |
Anti-SSA/SSB or RF plus ANA ≥1:320 | 21 (77.8) | 4 (50.0) | 4 (26.7) | 1 (1.8) |
Focus score ≥1 | 24 (88.9) | 7 (87.5) | 11 (73.3) | 6 (10.9) |